Benlysta
BENLYSTA is a prescription medicine, given intravenously (IV) or subcutaneously, for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines.
BENLYSTA is a prescription medicine, given intravenously (IV) or subcutaneously, for adults with active systemic lupus erythematosus (SLE or lupus) or active lupus nephritis on other lupus medicines.
For people older than 5 years of age with lupus or adults with active lupus nephritis, BENLYSTA can be given through IV infusion. When you are administered BENLYSTA by your healthcare provider, you’ll be monitored before, during, and immediately after the infusion.
You and your doctor will decide where you’ll receive your infusions: at the doctor’s office, an infusion center, or a hospital.
Infusions take approximately 1 hour, but preparation time before and observation time after the infusion may vary.
For the first 3 infusions, BENLYSTA is given once every 2 weeks. After that, BENLYSTA is given once every 4 weeks.
Your doctor will help you schedule your IV infusions and determine your correct dose.
The most common side effects of BENLYSTA include:
These are not all the possible side effects of BENLYSTA. Call your doctor for medical advice about side effects.